{"nct_id":"NCT04817007","title":"A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2021-03-22","start_date_type":"ACTUAL","primary_completion_date":"2026-05-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-05-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}